What are the NCCN treatment guidelines for locally advanced pancreatic cancer?

Updated: Oct 02, 2020
  • Author: Tomislav Dragovich, MD, PhD; Chief Editor: N Joseph Espat, MD, MS, FACS  more...
  • Print

NCCN treatment guidelines include the following recommendations [2] :

  • FOLFIRINOX/modified FOLFIRINOX or gemcitabine plus nab-paclitaxel is a first-line treatment for patients who have good performance status

  • Gemcitabine monotherapy, or palliative therapy and best supportive care, is recommended for locally advanced unresectable disease in symptomatic patients with poor performance status

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!